您当前所在的位置:首页 > 产品中心 > 产品详细信息
27469-53-0 分子结构
点击图片或这里关闭

6-{4-[bis(4-fluorophenyl)methyl]piperazin-1-yl}-2-N,4-N-bis(prop-2-en-1-yl)-1,3,5-triazine-2,4-diamine

ChemBase编号:1238
分子式:C26H29F2N7
平均质量:477.5521664
单一同位素质量:477.2452504
SMILES和InChIs

SMILES:
Fc1ccc(C(N2CCN(CC2)c2nc(nc(n2)NCC=C)NCC=C)c2ccc(F)cc2)cc1
Canonical SMILES:
C=CCNc1nc(nc(n1)NCC=C)N1CCN(CC1)C(c1ccc(cc1)F)c1ccc(cc1)F
InChI:
InChI=1S/C26H29F2N7/c1-3-13-29-24-31-25(30-14-4-2)33-26(32-24)35-17-15-34(16-18-35)23(19-5-9-21(27)10-6-19)20-7-11-22(28)12-8-20/h3-12,23H,1-2,13-18H2,(H2,29,30,31,32,33)
InChIKey:
OBDOVFRMEYHSQB-UHFFFAOYSA-N

引用这个纪录

CBID:1238 http://www.chembase.cn/molecule-1238.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
6-{4-[bis(4-fluorophenyl)methyl]piperazin-1-yl}-2-N,4-N-bis(prop-2-en-1-yl)-1,3,5-triazine-2,4-diamine
IUPAC传统名
almitrine
商标名
Vectarion
Duxil
Doxil
别名
Almitrine mesylate
Almitrine dimesylate
Almitrine bismesylate
Almitrine
CAS号
27469-53-0
PubChem SID
46505517
160964698
PubChem CID
33887

数据来源

数据来源

所有数据来源 商品来源 非商品来源
数据来源 数据ID
DrugBank DB01430 external link
PubChem 33887 external link
数据来源 数据ID 价格

理论计算性质

理论计算性质

JChem ALOGPS 2.1
Acid pKa 14.271289  质子受体
质子供体 LogD (pH = 5.5) 3.8133168 
LogD (pH = 7.4) 5.6966276  Log P 6.0494266 
摩尔折射率 140.8795 cm3 极化性 50.13021 Å3
极化表面积 69.21 Å2 可自由旋转的化学键 10 
里宾斯基五规则 false 
Log P 4.9  LOG S -4.52 
溶解度 1.44e-02 g/l 

分子性质

分子性质

生物活性(PubChem)

详细说明

详细说明

DrugBank DrugBank
DrugBank -  DB01430 external link
Item Information
Drug Groups approved
Description A respiratory stimulant that enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. The drug increases arterial oxygen tension while decreasing arterial carbon dioxide tension in patients with chronic obstructive pulmonary disease. It may also prove useful in the treatment of nocturnal oxygen desaturation without impairing the quality of sleep. [PubChem]
Indication For the treatment of chronic obstructive pulmonary disease.
Pharmacology Almitrine is a respiratory stimulant that enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. The drug increases arterial oxygen tension while decreasing arterial carbon dioxide tension in patients with chronic obstructive pulmonary disease. It may also prove useful in the treatment of nocturnal oxygen desaturation without impairing the quality of sleep.
Affected Organisms
Humans and other mammals
External Links
Wikipedia

参考文献

参考文献

供应商提供 Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
    暂无数据
正在搜索,请耐心等待...(如果遇到网页错误或者长时间没有结果,请刷新页面[F5])

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle